At a specially convened meeting, shareholders of Advanced Medical Solutions Group plc (AMS) approved H.B. Fuller’s proposed acquisition of the company. H.B. Fuller reports that the approval by AMS shareholders represents a significant milestone towards completion of the transaction and follows the agreement on the terms of a recommended cash acquisition previously announced by the companies on June 25, 2026.

"We are pleased with this significant milestone," said Celeste Mastin, president and chief executive officer of H.B. Fuller. "AMS is an exceptional company and a rare strategic fit that advances our vision for the future of H.B. Fuller. By combining AMS's leading medical technologies, innovation expertise, and regulatory capabilities with H.B. Fuller's global scale and commercial reach, we will create a differentiated healthcare platform positioned for faster growth, stronger margins, and greater value creation. We are excited to welcome the AMS team and begin the next chapter together."